Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO2 Laser Therapy for GSM in Cancer Survivors
NCT06318052Recruiting
- Sponsor
- Lumenis
- Start
- Nov 2019
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
Randomised trial (2 arms), sponsored by Lumenis. Primary endpoint: Efficacy of fractionated CO2 laser treatments at 1 year. Started Nov 2019; status: recruiting.
Beyond the preview
Go deeper on NCT06318052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06318052.